
What is a Medicare advisor?
Navigating Medicare can be confusing. However, Medicare advisors can help you understand the different parts, costs, and coverage.
It is important to check their licensing before choosing which one to use.
Types of Medicare advisors
There are different types of Medicare advisors — the two main types are brokers and agents.
Medicare brokers
A Medicare broker is a licensed individual who represents multiple insurance companies. They can help you evaluate plan options.
As Medicare brokers are not tied to a particular insurance company, they can help walk you through various plans from different companies to find the best one for your coverage needs and budget. Once they help you choose a plan, they will then connect you with an agent from the insurance company to help you with the enrollment process.
A Medicare broker may be the best option if you are unfamiliar with the insurance companies that offer Medicare Advantage (Part C), Part D, or Medigap plans and want to compare a variety of plans.
Medicare agents
Medicare agents are licensed individuals who help enroll people in various insurance products, such as Medicare Advantage, Part D, and Medigap.
There are two types of Medicare agents:
Independent: An independent agent is a contractor who represents different insurance companies. They search for the best plans based on each client's individual needs.
Captive: A captive agent is an individual who represents an individual insurance company and is required to sell only plans from that company.
Federal requirements for Medicare agents
hold a license in the states where they do business
use approved marketing materials
test and train annually on their knowledge of Medicare health and prescription drug plans
agree to the scope of appointment via document or phone call before meeting with potential enrollees
SHIP volunteers
The State Health Insurance Assistance Program (SHIP) is a federally funded state-based organization that provides Medicare counseling and information to beneficiaries and their caregivers.
SHIP counselors are all volunteers. They offer unbiased one-to-one counseling and assistance. SHIP also screens, trains, and certifies all its volunteers as Medicare experts.
To contact SHIP, you can call 877-839-2675 or find your local SHIP office.
Contacting Medicare
You can contact Medicare directly with any questions you may have. The Medicare line is open 24/7, except for certain federal holidays.
How do Medicare advisors get paid?
It is rare for a beneficiary to pay a Medicare advisor anything out of pocket. Generally, Medicare advisors are paid via commission for enrollment and retention in Medicare Advantage, Part D, and Medigap plans.
They may also be offered further compensation for:
administrative payments for marketing
bonuses for meeting enrollment benchmarks
selling other health-related insurance products, such as hospital indemnity insurance
other activities for plans, such as beneficiary health risk assessments
The Centers for Medicare & Medicaid Services (CMS) requires that agent compensation for Medicare Advantage and Medicare Part D plans be at or below fair market value. The following table gives examples of compensation for 2025.
Compensation type National maximum
Medicare Advantage initial year $626
Medicare Advantage renewal year $313
Medicare Part D initial year $109
Medicare Part D renewal year $55
For each Medicare Advantage or Plan D plan renewal or switch to a new similar plan, the Medicare advisor is paid up to 50% of the fair market value. For Medigap plans, agents are given about 20% initial enrollment and 10% for each subsequent year.
What to look for when choosing a Medicare advisor
When choosing a Medicare advisor, there are certain criteria you may want to consider:
Licenses: Be sure to check that your chosen advisor is licensed by your state insurance department, as required by CMS. Also, check to be sure they are a member of the AHIP, the national trade association for the health insurance industry.
Scope of services: Consider the services an advisor offers. If you are unfamiliar with the top companies that provide Medicare plans, a Medicare broker may be a better option. If you would rather work with only one intermediary, an agent may be more suitable.
Support offered: Consider whether the Medicare advisor will provide support if you have questions or run into problems after you purchase a plan.
Summary
Medicare advisors are licensed individuals who can help you choose and enroll in a Medicare plan. There are two main types of Medicare Advisors — brokers and agents. Each one of these can help you in different ways.
You can also contact the State Health Insurance Assistance Program (SHIP) and get unbiased one-to-one counseling on Medicare issues and questions. Medicare also has a helpline that you can call or chat online with 24/7.
The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
29 minutes ago
- Business Insider
CVS vs. UNH: Which Healthcare Stock is a Better Buy After Q2 Earnings?
CVS Health (CVS) and UnitedHealth Group (UNH), two of the largest players in the healthcare sector, recently reported their Q2 earnings, showing contrasting performances. While CVS delivered strong revenue growth and raised its full-year guidance, UnitedHealth faced challenges with declining earnings and released a cautious outlook. This article compares the two stocks to help investors decide which healthcare giant offers a better buying opportunity after the latest results. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Is CVS a Good Stock to Buy Now? CVS has shown steady performance compared to its competitors and made a strong recovery in 2025 after several challenging years. So far this year, its stock has climbed more than 45%. For Q2, the company posted results that exceeded expectations. Notably, the Health Care Benefits segment, which includes Aetna, achieved a 39% increase in adjusted operating income. In response to these positive results, CVS raised its full-year adjusted EPS guidance to a range of $6.30 to $6.40, up from the previous $6.00 to $6.20. The company is also rolling out a $2 billion, multi-year cost-saving plan, with expected 2025 savings set to fully cover rising variable costs. These strategic initiatives and financial metrics underscore CVS Health's strong position in the healthcare sector, making it an attractive option for investors seeking stability and growth. Is UNH a Good Buy Right Now? On the other hand, UnitedHealth has faced several difficulties recently. In April, it reported higher-than-expected medical costs in its Medicare division. In May, the company pulled its full-year financial forecast, and CEO Andrew Witty resigned unexpectedly for personal reasons. Earlier this month, UnitedHealth's stock hit a new 52-week low, falling 51% over the past six months. Interestingly, UnitedHealth's Q2 results added to its challenges. The company missed earnings expectations, reporting $4.08 per share compared to the $4.45 forecast. Additionally, the company issued a weaker profit guidance for the full year. This new outlook factors in the company's performance in the first half of 2025 and expected increases in medical costs for the rest of the year. Despite the challenges, UnitedHealth's steady revenue base, ongoing investments, and expectations for earnings growth in 2026 make it an attractive option for investors willing to look past short-term setbacks. However, cautious investors should monitor how the company manages cost pressures and carries out its plans going forward. Which Healthcare Stock Is a Strong Buy, According to Analysts? Using the TipRanks Stock Comparison tool, we compared these healthcare stocks. Among these companies, CVS stock has earned a Strong Buy rating from analysts, while UNH stock carries a Moderate Buy. In terms of share price appreciation, CVS's average stock price target of $81.75 offers an upside potential of 19% from current levels. In contrast, UNH's stock price forecast of $312.65 suggests a growth rate of just 1%. Conclusion Among the stocks, CVS currently stands out as the better investment option, according to analysts. It holds a stronger analyst rating, a higher projected upside, and has demonstrated solid recent performance with raised earnings guidance. While UNH remains a strong player with long-term potential, CVS's current momentum and outlook may offer a more appealing option for investors.


Business Insider
2 hours ago
- Business Insider
Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2
Billionaire investor David Tepper increased his stake in the struggling health insurance giant, UnitedHealth (UNH), during Q2. His move mirrors Warren Buffett 's Berkshire Hathaway (BRK.B), which also revealed a new $1.57 billion stake in UNH stock. Further, Michael Burry's Scion Asset Management bought calls on 350,000 shares. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. UNH stock gained 14% on Friday as bullish bets from Top hedge funds boosted investor hopes for a rebound. According to a recent 13F filing, Tepper's Appaloosa Management LP added 2.3 million shares of UNH, bringing the total value of the stake to $764 million. This makes UNH the fund's second-largest holding after Chinese e-commerce giant Alibaba (BABA). Tepper's bet comes at a turbulent time for UnitedHealth, which is dealing with a criminal probe into Medicare billing, a CEO shakeup, and the aftermath of a massive cyberattack. UNH stock has plunged about 40% year-to-date. Tepper Shifts Strategy on China Tepper's bet on UNH aligns with his investment strategy, which involves making bold bets on companies that others are avoiding. It is similar to his earlier investment in Chinese stocks, which he began buying last year when many investors were pulling back over economic and geopolitical concerns. It must be noted that those investments paid off as China's MSCI benchmark surged 46% over the past year due to Beijing's economic stimulus efforts. However, Tepper is now taking a more cautious approach. The fund reduced its holdings in major Chinese companies amid rising trade tensions. Appaloosa cut its stake in Alibaba by over 20% and also trimmed its positions in (JD), Baidu (BIDU), and PDD Holdings (PDD). Tepper's Other Bullish Bets Apart from UNH, the investor also ramped up his stake in Nvidia (NVDA), adding 1.45 million shares for a total of 1.75 million. This 483% increase brings the position's value to over $276 million. Also, he made some notable new investments last quarter. These include tech giant Intel (INTC), with 8 million shares valued at $179.2 million, and aerospace and defense company RTX (RTX), with 585,000 shares worth $85.4 million. The third-largest new buy is health information technology and clinical research provider IQVIA Holdings (IQV), with 300,000 shares valued at $47.3 million. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, four Holds, and two Sells assigned in the last three months. At $312.65, the average UnitedHealth stock price target implies a 2.17% upside potential.


Los Angeles Times
3 hours ago
- Los Angeles Times
UnitedHealth Group shares climb as Buffett's Berkshire Hathaway discloses stake in the insurer
Shares of UnitedHealth Group are surging before the market open Friday as Warren Buffett's Berkshire Hathaway disclosed that it recently purchased shares of the beleaguered insurer. Berkshire Hathaway bought around 5 million shares of UnitedHealth last quarter, according to a regulatory filing. The stake was valued at about $1.57 billion. Buffett plans to retire as CEO at the end of the year after six decades of building Berkshire Hathaway. Many investors comb through Berkshire's filings every quarter because they like to follow Buffett's moves. The filing doesn't make clear who at Berkshire handled the investment. Besides Buffett, Ted Weschler and Todd Combs also pick stocks, but they generally handle smaller portfolios and Combs also serves as Geico's CEO. Besides stocks, Berkshire owns dozens of companies in a variety of industries including Geico insurance, BNSF railroad, several major utilities and an assortment of manufacturing and retail companies. The Omaha, Nebraska-based company's holdings include many well-known brands like See's Candy and Dairy Queen. UnitedHealth has been dealing with a series of difficulties. Last month the company said that it was cooperating with federal criminal and civil investigations involving its market-leading Medicare business. The health care giant said at the time that it had contacted the Department of Justice after reviewing media reports about investigations into certain elements of its business. Earlier this year, The Wall Street Journal said federal officials had launched a civil fraud investigation into how the company records diagnoses that lead to extra payments for its Medicare Advantage, or MA, plans. Those are privately run versions of the government's Medicare coverage program mostly for people ages 65 and over. The company's UnitedHealthcare business covers more than 8 million people as the nation's largest provider of Medicare Advantage plans. The business has been under pressure in recent quarters due to rising care use and rate cuts. The Journal said in February, citing anonymous sources, that the probe focused on billing practices in recent months. The paper has since said that a federal criminal health care-fraud unit was investigating how the company used doctors and nurses to gather diagnoses that bolster payments. UnitedHealth Group Inc. runs one of the nation's largest health insurance and pharmacy benefits management businesses. It also operates a growing Optum business that provides care and technology support. UnitedHealth's stock has mostly shed value since December, when UnitedHealthcare CEO Brian Thompson was fatally shot in midtown Manhattan on his way to the company's annual investor meeting. A suspect, Luigi Mangione, has been charged in connection with the shooting. In April, shares plunged some more after the company cut its forecast due to a spike in health care use. A month later, former CEO Andrew Witty resigned, and the company withdrew its forecast entirely, saying that medical costs from new Medicare Advantage members were higher than expected. UnitedHealth's stock jumped more than 12% in premarket trading on Friday. Still, the stock has lost roughly half its value in the past year. Chapman writes for the Associated Press.